- Phare
- Validé par KD/KO
Anticorps Monoclonal anti-RhoGDI
RhoGDI Monoclonal Antibody for WB, Indirect ELISA
Hôte / Isotype
Mouse / IgG2a
Réactivité testée
Humain, rat, souris
Applications
WB, Indirect ELISA
Conjugaison
Non conjugué
CloneNo.
1B1G9
N° de cat : 66480-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
66480-1-PBS cible RhoGDI dans les applications de WB, Indirect ELISA et montre une réactivité avec des échantillons Humain, rat, souris
| Réactivité | Humain, rat, souris |
| Hôte / Isotype | Mouse / IgG2a |
| Clonalité | Monoclonal |
| Type | Anticorps |
| Immunogène | RhoGDI Protéine recombinante Ag0791 |
| Nom complet | Rho GDP dissociation inhibitor (GDI) alpha |
| Masse moléculaire calculée | 28 kDa |
| Poids moléculaire observé | 28 kDa |
| Numéro d’acquisition GenBank | BC005851 |
| Symbole du gène | RhoGDI |
| Identification du gène (NCBI) | 396 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par protéine A |
| Tampon de stockage | PBS only |
| Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
Rho GDP-dissociation inhibitor (RhoGDI), also called ARHGDIA, is one member of ARHGDIs, which is ubiquitously expressed and interacts with several Rho GTPases, mainly including RhoA, Rac1, and Cdc42. RhoGDI can inhibit nucleotide exchange and membrane association to downregulate the activities of Rho family GTPase. It is overexpressed in various human cancers. Activity of this protein is important in a variety of cellular processes, and it is overexpressed in various human cancers. Mutations in RhoGDI have been found in individuals with nephrotic syndrome, type 8.





